Patents by Inventor Scott D. Estes

Scott D. Estes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002785
    Abstract: Described herein are methods for the production of extracellular vesicles comprising culturing a population of producer cells in single-cell suspension, wherein the cells are cultured in chemically-defined culture medium, wherein the culture medium lacks animal-derived serum and animal-derived components; and obtaining from the cell culture an extracellular vesicle preparation comprising extracellular vesicles. In certain embodiments, the methods comprise perfusion culturing methods, including single-cell perfusion culturing methods and batch-refeed culturing methods. The methods described herein are a significant improvement over the state of the art and fulfills an unmet need in the field of extracellular vesicle manufacturing and quality control.
    Type: Application
    Filed: February 21, 2023
    Publication date: January 4, 2024
    Applicant: LONZA SALES AG
    Inventors: Agata A. VILLIGER, Andrew F. GRUBE, Tik Yan CHAN, Scott D. ESTES, Kathryn E. GOLDEN, Konstantin KONSTANTINOV, Douglas E. WILLIAMS
  • Publication number: 20190300880
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Application
    Filed: March 12, 2019
    Publication date: October 3, 2019
    Inventors: Scott D. ESTES, Weiqun ZHANG
  • Patent number: 10273479
    Abstract: The invention relates to isolation of novel ?-actin promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters, including rat ?-actin promoter.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: April 30, 2019
    Assignee: GENZYME CORPORATION
    Inventors: Scott D. Estes, Weiqun Zhang
  • Publication number: 20190085284
    Abstract: Described herein are methods for the production of extracellular vesicles comprising culturing a population of producer cells in single-cell suspension, wherein the cells are cultured in chemically-defined culture medium, wherein the culture medium lacks animal-derived serum and animal-derived components; and obtaining from the cell culture an extracellular vesicle preparation comprising extracellular vesicles. In certain embodiments, the methods comprise perfusion culturing methods, including single-cell perfusion culturing methods and batch-refeed culturing methods. The methods described herein are a significant improvement over the state of the art and fulfills an unmet need in the field of extracellular vesicle manufacturing and quality control.
    Type: Application
    Filed: September 20, 2018
    Publication date: March 21, 2019
    Inventors: Agata A. Villiger, Andrew F. Grube, Tik Yan Chan, Scott D. Estes, Kathryn E. Golden, Konstantin Konstantinov, Douglas E. Williams
  • Publication number: 20180155722
    Abstract: The invention relates to isolation of novel ?-actin promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including ?-actin promoter.
    Type: Application
    Filed: November 10, 2017
    Publication date: June 7, 2018
    Inventors: Scott D. ESTES, Weiqun ZHANG
  • Patent number: 9920318
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: March 20, 2018
    Assignee: GENZYME CORPORATION
    Inventors: Scott D. Estes, Weiqun Zhang
  • Publication number: 20150040252
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Application
    Filed: August 1, 2014
    Publication date: February 5, 2015
    Applicant: GENZYME CORPORATION
    Inventors: Scott D. ESTES, Weiqun ZHANG
  • Patent number: 8829176
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Grant
    Filed: July 15, 2008
    Date of Patent: September 9, 2014
    Assignee: Genzyme Corporation
    Inventors: Scott D. Estes, Weiqun Zhang
  • Publication number: 20080301826
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Application
    Filed: July 15, 2008
    Publication date: December 4, 2008
    Inventors: Scott D. ESTES, Weiqun Zhang
  • Patent number: 7423135
    Abstract: The invention relates to isolation of novel ?-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent ?-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter.
    Type: Grant
    Filed: June 24, 2004
    Date of Patent: September 9, 2008
    Assignee: Genzyme Corporation
    Inventors: Scott D. Estes, Weiqun Zhang
  • Patent number: 5681706
    Abstract: Genetic regulatory elements which effect anoxic induction of a DNA molecule in mammalian cells exposed to anoxia are identified. The genetic regulatory elements, designated mammalian anoxia-responsive elements, when operably linked to a DNA molecule and basal promoter regulate the transcription of the DNA molecule in response to anoxia. The invention relates to recombinant vectors useful for introduction into mammalian cells, and the selective expression in mammalian cells exposed to anoxic conditions. Also provided are methods of using such vectors.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: October 28, 1997
    Assignee: Health Research Inc.
    Inventors: Garth R. Anderson, Scott D. Estes, Daniel L. Stoler